Abstract: A device assembly for accommodating an electrically operated device may include a housing made from a plastic, delimiting a housing interior space, and having a viewing window formed therein that may be closed by a window pane made of a transparent material. The device may include an electrically operated device arranged inside the housing interior space, on the outside of which at least one actuatable control element may be provided. An aperture may be formed in a housing wall in which an actuating element made from an elastic plastic may be arranged at least partially and may be operable by a user of the electrically operated device. The actuating element may be coupled mechanically to the control element such that the control element is operable from outside the housing. An inner housing part made from an elastic plastic may be arranged on an inner side of the housing wall.

Abstract: A device assembly for accommodating an electrically operated device may include a housing made from a plastic, delimiting a housing interior space, and having a viewing window formed therein that may be closed by a window pane made of a transparent material. The device may include an electrically operated device arranged inside the housing interior space, on the outside of which at least one actuatable control element may be provided. An aperture may be formed in a housing wall in which an actuating element made from an elastic plastic may be arranged at least partially and may be operable by a user of the electrically operated device. The actuating element may be coupled mechanically to the control element such that the control element is operable from outside the housing. An inner housing part made from an elastic plastic may be arranged on an inner side of the housing wall.

Abstract: Recombinant materials, including DNA constructs, expression vectors, and host cells, and methods of identifying an environmental stimulus or a gene that alters the lifespan of an organism are identified. The recombinant DNA constructs include first and second chimeric genes that both encode substantially the same protein that is required for yeast replication, the first chimeric gene containing a promoter responsive to growth medium conditions and the second chimeric gene containing a promoter operable in mother cells but not daughter cells.

Abstract: In at least one aspect of the invention, systems are provided that comprise at least one computing device coupled to a plurality of other computing devices that are operable to retrieve market data for a plurality of risk reversals for a currency pair, determine a currency in which to quote skew for each of the risk reversals at a first time, determine that there has been a change in skew, and cause an interface screen to be displayed at least one of the other computing devices with a listing comprising the first and second risk reversals, the market data, and an indication of the change in skew of the at least one of the risk reversals.

Abstract: The invention relates to polypeptides made of mannitol-dehydrogenase of Cladosporium herbarum and Alternaria alternata nucleic acids coding therefor and the use thereof in diagnosis and therapy.

Abstract: The invention relates to DNA molecules which code for the allergen Art v 1 or isoforms thereof, the sequence of the allergen, a method for the production of an Art v 1 molecule, a vector and a transformed host cell.

Abstract: The invention relates to polypeptides made of mannitol-dehydrogenase of Cladosporium herbarum and Alternaria alternata nucleic acids coding therefor and the use thereof in diagnosis and therapy.

Abstract: The invention relates to a method by which expression cDNA clone banks are screened by means of IgE antibodies derived from the sera of allergic individuals, or by means of monoclonal or polyclonal antibodies. This type of screening is used for the detection of polynucleotides whose open-reading frames code for allergenically active proteins. These proteins are characterized in that their biological activity as allergens is equal to that of plant allergens occurring in nature.

Abstract: The invention relates to a method by which expression cDNA clone banks are screened by means of IgE antibodies derived from the sera of allergic individuals, or by means of monoclonal or polyconal antibodies. This type of screening is used for the detection of polynucleotides whose open-reading frames code for allergenically active proteins. These proteins are characterized in that their biological activity as allergens is equal to that of plant allergens occurring in nature.

Abstract: This invention provides recombinant DNA molecules which code for polypeptides that exhibit the antigenicity of an Aln g I allergen of alder, Alnus sp., of a Cor a I allergen of hazel or of a Bet v I allergen of birch and other plants of the order Fageles, and for polypeptides comprising at least one epitope thereof, as well as nucleic acids which under stringent conditions hybridize with such DNA sequences or are derivable from such sequences by degeneracy of the genetic code. In addition, methods are described for using the polypeptides coded by these DNA molecules and their use in the diagnosis or therapy of allergic diseases.

Abstract: The invention provides recombinant DNA molecules which code for polypeptides that exhibit the antigenicity of a P14 allergen of birch Betula verrucosa and other plants of the order Fagales, and for polypeptides comprising at least one epitope thereof, as well as nucleic acids which under stringent conditions hybridize with such DNA sequences or are derivable from such sequences by degeneracy of the genetic code. A method is provided that permits purification of P14 allergens or cross reactive allergens by means of binding to poly(L-proline). In addition, methods are described for making the proteins and polypeptides coded by these DNA molecules and their use in the diagnosis or therapy of diseases.

Abstract: The invention provides recombinant DNA molecules which code for proteins or polypeptides that exhibit the antigenicity of a P14 allergen of birch Betula verrucosa and other plants of the order Fagales, and for polypeptides comprising at least one epitope thereof, as well as nucleic acids which under stringent conditions hybridize with such DNA sequences or are derivable from such sequences by degeneracy of the genetic code. A method is provided that permits purification of P14 allergens or cross-reactive allergens by means of binding to poly(L-proline). In addition, methods are described for making the proteins and polypeptides coded by these DNA molecules and their use in the diagnosis or therapy of allergic diseases.